• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during pregnancy and breastfeeding is a challenge for women suffering from the condition. There aren't enough data on how long-term exposure may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental disorders such as impaired vision or hearing seizures, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are required.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it against the possible risks for the foetus. Physicians do not have the data needed to provide clear recommendations, but they can provide information regarding benefits and risks that can aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to make sure that the classification was correct and to eliminate any bias.

However, academy01.netpro.co.kr the researchers' study had its limitations. The researchers were unable in the beginning to differentiate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to establish whether the small differences observed between the groups exposed were due to medication use, or if they were confounded by co-morbidities. Researchers also did not examine the long-term effects for the offspring.

The study did show that babies whose mothers had taken ADHD medication during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had stopped their medications before or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk of admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the type of medication that was used during pregnancy.

Researchers suggest that the small risk of using ADHD medications in early pregnancies can be offset by greater benefits for mother and baby of continuing treatment for the woman's disorder. Physicians should speak with their patients about this issue and as much as possible, assist them develop coping skills that can lessen the effects of her disorder on her daily life and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of solid and reliable evidence either way, so physicians must weigh their knowledge about their experiences, the experiences of other doctors, and what research says on the topic, along with their best medication for ocd and adhd judgment for each patient.

The issue of possible risks to the infant can be particularly tricky. The research that has been conducted on this topic is based on observation rather than controlled studies, and the results are conflicting. The majority of studies focus on live births, which may underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study presented in the journal club addresses these issues, by examining both the data from deceased and live births.

The conclusion The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link, and most studies demonstrate a neutral or slightly negative effect. In the end, a careful risk/benefit analysis must be conducted in every case.

For many women with ADHD who suffer from ADHD, the decision to discontinue medication for autism and adhd can be difficult, if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. Furthermore, a loss of medication can interfere with the ability to perform work-related tasks and safely drive that are crucial aspects of daily life for many people with ADHD.

She recommends women who are unsure about whether to keep or stop taking medication because of their pregnancy, consider informing family members, friends and colleagues about the condition, its effects on daily life, and the advantages of continuing the current treatment regimen. It can also help women feel more confident in her decision. It is important to note that certain drugs can pass through the placenta so if a woman decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the medication could be passed on to the baby.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the drugs might have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Utilizing two huge data sets researchers were able look at more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester adhd anxiety medication exposure to medication was associated with slightly higher risk types of adhd medication specific heart defects such as ventriculoseptal defect.

The authors of the study could not find any association between the use of early medications and other congenital anomalies, like facial deformities or club feet. The results are in the same vein as previous studies that have shown the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication before pregnancy. The risk was higher during the latter part of pregnancy, when many women decide to stop taking their ADHD medications.

Women who took ADHD medications in the first trimester of pregnancy were also more likely to undergo a caesarean section, a low Apgar score following delivery, and a baby that required breathing assistance during birth. The authors of the study were unable to remove bias in selection since they restricted the study to women with no other medical conditions that could have contributed to the findings.

Researchers hope that their study will provide doctors with information when they encounter pregnant women. They advise that while the discussion of over the counter adhd medication risks and benefits is crucial but the decision to stop or continue treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, even though stopping the medication is an option to look into, it is not advised due to the high rate depression and other mental problems among women who are pregnant or who have recently given birth. Further, research shows that women who stop taking their medication will have a harder time adjusting to a life without them after the baby is born.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women who suffer from Adhd medication pregnancy may face a lot of challenges when they must deal with their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new routines. Therefore, many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medications are absorbed through breast milk in low amounts, so the risk to nursing infant is very low. However, the amount of exposure to medications by the newborn may differ based on the dosage, frequency it is taken and the time of day the medication is administered. In addition, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn infant is not fully understood.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult decision for the woman, who must weigh the advantages of taking her medication as well as the risks to the fetus. In the meantime, until more information is available, doctors can inquire about pregnant patients if they have a history of ADHD or if they intend to take medication in the perinatal period.

A growing number of studies have shown that women can continue their ADHD medication during pregnancy and breastfeeding. As a result, more and more patients choose to do so and in consultation with their physician, they have found that the benefits of keeping their current medication far outweigh any risks.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should discuss the medication they are taking with their physician as well as the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of their symptoms and the underlying disorder and learn about treatment options and strengthen existing strategies for coping. This should be a multidisciplinary approach with the GP, obstetricians and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, monitoring of signs of deterioration, and, if necessary modifications to the medication regime.